Blocking overactive complement system demonstrates promise in treating severe COVID-19

Clinical trial completion rates decline during COVID-19 pandemic

Covid-19 news: UK to offer under-30s alternative to AstraZeneca jab

AstraZeneca COVID-19 vaccine causes very rare blood clots, EU regulator says